KEGG   PATHWAY: pleu05216
Entry
pleu05216                   Pathway                                
Name
Thyroid cancer - Peromyscus leucopus (white-footed mouse)
Description
Thyroid cancer is the most common endocrine malignancy and accounts for the majority of endocrine cancer- related deaths each year. More than 95% of thyroid carcinomas are derived from follicular cells. Their behavior varies from the indolent growing, well-differentiated papillary and follicular carcinomas (PTC and FTC, respectively) to the extremely aggressive undifferentiated carcinoma (UC). Somatic rearrangements of RET and TRK are almost exclusively found in PTC and may be found in early stages. The most distinctive molecular features of FTC are the prominence of aneuploidy and the high prevalence of RAS mutations and PAX8-PPAR{gamma} rearrangements. p53 seems to play a crucial role in the dedifferentiation process of thyroid carcinoma.
Class
Human Diseases; Cancer: specific types
Pathway map
pleu05216  Thyroid cancer
pleu05216

Disease
H00032  Thyroid cancer
Organism
Peromyscus leucopus (white-footed mouse) [GN:pleu]
Gene
114681270  Ctnnb1; catenin beta-1 isoform X1 [KO:K02105]
114681591  Tcf7l1; transcription factor 7-like 1 isoform X1 [KO:K04490]
114682732  Mapk1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
114682816  Lef1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
114683055  Tcf7; transcription factor 7 isoform X2 [KO:K02620]
114683361  Ntrk1; high affinity nerve growth factor receptor isoform X1 [KO:K03176] [EC:2.7.10.1]
114683440  [KO:K05689]
114684640  Bax; apoptosis regulator BAX isoform X1 [KO:K02159]
114685127  [KO:K02833]
114686359  Rxrb; retinoic acid receptor RXR-beta isoform X1 [KO:K08525]
114688121  Map2k2; dual specificity mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
114688301  Gadd45b; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
114688488  [KO:K02833]
114689482  Gadd45g; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
114689632  Pparg; peroxisome proliferator-activated receptor gamma isoform X1 [KO:K08530]
114689662  Ret; proto-oncogene tyrosine-protein kinase receptor Ret [KO:K05126] [EC:2.7.10.1]
114689910  Rxrg; retinoic acid receptor RXR-gamma isoform X1 [KO:K08526]
114691497  Map2k1; dual specificity mitogen-activated protein kinase kinase 1 isoform X2 [KO:K04368] [EC:2.7.12.2]
114691932  Tfg; protein TFG isoform X1 [KO:K09292]
114692753  Pax8; paired box protein Pax-8 isoform X2 [KO:K09293]
114693171  Tp53; cellular tumor antigen p53 [KO:K04451]
114693493  [KO:K02833]
114693595  Hras; GTPase HRas isoform X1 [KO:K02833]
114694498  Ccnd1; G1/S-specific cyclin-D1 isoform X2 [KO:K04503]
114694653  Polk; DNA polymerase kappa isoform X1 [KO:K03511] [EC:2.7.7.7]
114696553  [KO:K02833]
114696778  Tpr; LOW QUALITY PROTEIN: nucleoprotein TPR [KO:K09291]
114697060  Tcf7l2; transcription factor 7-like 2 isoform X1 [KO:K04491]
114698535  Ccdc6; LOW QUALITY PROTEIN: coiled-coil domain-containing protein 6 [KO:K09288]
114698582  Nras; GTPase NRas [KO:K07828]
114699359  Ncoa4; nuclear receptor coactivator 4 isoform X1 [KO:K09289]
114699687  Ddb2; DNA damage-binding protein 2 [KO:K10140]
114700921  Gadd45a; growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
114701991  Myc; myc proto-oncogene protein [KO:K04377]
114702794  Rxra; retinoic acid receptor RXR-alpha [KO:K08524]
114704332  Mapk3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
114706143  Bak1; bcl-2 homologous antagonist/killer isoform X1 [KO:K14021]
114706157  Cdkn1a; cyclin-dependent kinase inhibitor 1 [KO:K06625]
114706830  Braf; LOW QUALITY PROTEIN: serine/threonine-protein kinase B-raf [KO:K04365] [EC:2.7.11.1]
114707877  Tpm3; tropomyosin alpha-3 chain isoform X12 [KO:K09290]
114708477  Kras; GTPase KRas isoform X2 [KO:K07827]
114710523  [KO:K04371] [EC:2.7.11.24]
Reference
  Authors
Kondo T, Ezzat S, Asa SL.
  Title
Pathogenetic mechanisms in thyroid follicular-cell neoplasia.
  Journal
Nat Rev Cancer 6:292-306 (2006)
DOI:10.1038/nrc1836
Reference
  Authors
Chiloeches A, Marais R.
  Title
Is BRAF the Achilles' Heel of thyroid cancer?
  Journal
Clin Cancer Res 12:1661-4 (2006)
DOI:10.1158/1078-0432.CCR-06-0051
Reference
  Authors
Reddi HV, McIver B, Grebe SK, Eberhardt NL
  Title
The paired box-8/peroxisome proliferator-activated receptor-gamma oncogene in thyroid tumorigenesis.
  Journal
Endocrinology 148:932-5 (2007)
DOI:10.1210/en.2006-0926
Reference
  Authors
Santoro M, Melillo RM, Fusco A.
  Title
RET/PTC activation in papillary thyroid carcinoma: European Journal of Endocrinology Prize Lecture.
  Journal
Eur J Endocrinol 155:645-653 (2006)
DOI:10.1530/eje.1.02289
Reference
  Authors
Pierotti MA, Greco A.
  Title
Oncogenic rearrangements of the NTRK1/NGF receptor.
  Journal
Cancer Lett 232:90-8 (2006)
DOI:10.1016/j.canlet.2005.07.043
Reference
  Authors
Sobrinho-Simoes M, Preto A, Rocha AS, Castro P, Maximo V, Fonseca E, Soares P.
  Title
Molecular pathology of well-differentiated thyroid carcinomas.
  Journal
Virchows Arch 447:787-93 (2005)
DOI:10.1007/s00428-005-0065-5
Reference
  Authors
Gimm O.
  Title
Thyroid cancer.
  Journal
Cancer Lett 163:143-56 (2001)
DOI:10.1016/S0304-3835(00)00697-2
Reference
  Authors
Williams D.
  Title
Cancer after nuclear fallout: lessons from the Chernobyl accident.
  Journal
Nat Rev Cancer 2:543-9 (2002)
DOI:10.1038/nrc845
Related
pathway
pleu03320  PPAR signaling pathway
pleu04010  MAPK signaling pathway
pleu04115  p53 signaling pathway
pleu04310  Wnt signaling pathway
pleu04520  Adherens junction
KO pathway
ko05216   

DBGET integrated database retrieval system